Atara Biotherapeutics
ATRA
ATRA
43 hedge funds and large institutions have $31.5M invested in Atara Biotherapeutics in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.47% less ownership
Funds ownership: 42.58% → 41.12% (-1.5%)
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$841K | |
| 2 | +$332K | |
| 3 | +$293K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$169K |
| 5 |
Morgan Stanley
New York
|
+$162K |
Top Sellers
| 1 | -$2.21M | |
| 2 | -$353K | |
| 3 | -$141K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$62.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.7K |